Pulmonary arterial hypertension and left‐sided heart disease in sickle cell disease: Clinical characteristics and association with soluble adhesion molecule expression
Open Access
- 4 March 2008
- journal article
- research article
- Published by Wiley in American Journal of Hematology
- Vol. 83 (7), 547-553
- https://doi.org/10.1002/ajh.21187
Abstract
Pulmonary hypertension (PH), a risk factor for mortality in sickle cell disease (SCD), has pathologic features of both pulmonary arterial hypertension (PAH) and PH related to left-sided heart disease (LHD) suggesting a link between these two entities. We hypothesized that both are characterized by endothelial dysfunction and increased adhesion molecule expression. SCD patients and normal volunteers underwent a screening questionnaire, echocardiogram, and blood donation for preparation of platelet-poor plasma. PAH was defined as a tricuspid regurgitant jet (TRJ) velocity ≥2.5 m/sec and/or the presence of isolated right ventricular hypertrophy or decreased systolic function. LHD was defined as either left-sided systolic/diastolic dysfunction or significant valvular disease. Plasma vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1), P- and E-selectin, nitric oxide (NOx), erythropoietin, and vascular endothelial growth factor (VEGF) levels were assayed by enzyme-linked immunoassay. Forty-three percent of sickle cell anemia (HbSS) and 28% of hemoglobin SC disease (HbSC) disease patients had PAH. Additionally, 10–15% of SCD patients had LHD. VCAM-1 levels were significantly increased in HbSS patients compared with HbSC patients and normal volunteers. VCAM-1 and P-selectin levels correlated positively with TRJ velocity in HbSS patients (r = 0.45, P = 0.03, r = 0.2, P = 0.05, respectively). ICAM-1, E-selectin, NOx, erythropoietin, and VEGF levels were similar across subject groups. PH is common in SCD and, at times, due to LHD. Increased VCAM-1 and P-selectin expression was associated with TRJ elevation regardless of etiology suggesting a similar effect on endothelial gene expression and possibly providing a pathologic link between PAH and PH related to LHD in SCD. Am. J. Hematol. 2008.Keywords
This publication has 61 references indexed in Scilit:
- Redox-dependent impairment of vascular function in sickle cell diseaseFree Radical Biology & Medicine, 2007
- Hemodynamic and Functional Assessment of Patients with Sickle Cell Disease and Pulmonary HypertensionAmerican Journal of Respiratory and Critical Care Medicine, 2007
- PULMONARY HYPERTENSION IN SICKLE CELL DISEASE: Relevance to ChildrenPediatric Hematology and Oncology, 2007
- Deconstructing sickle cell disease: Reappraisal of the role of hemolysis in the development of clinical subphenotypesBlood Reviews, 2006
- Cerebrovascular disease associated with sickle cell pulmonary hypertensionAmerican Journal of Hematology, 2006
- New predictors of outcome in idiopathic pulmonary arterial hypertensionThe American Journal of Cardiology, 2005
- Severe deficiency of glycoprotein VI in a patient with gray platelet syndromeBlood, 2004
- Current Management of Primary Pulmonary HypertensionDrugs, 2001
- Noninvasive estimation of right atrial pressure from the inspiratory collapse of the inferior vena cavaThe American Journal of Cardiology, 1990
- Sickle Cell Chronic Lung DiseaseMedicine, 1988